Chang Hee Kwon

Dr. Chang Hee Kwon

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2012 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
CKChang Hee Kwon
Chang Hee Kwon
EREun-Jung Rhee
Eun-Jung Rhee
JSJae-Uk Song
Jae-Uk Song
JKJung-Tae Kim
Jung-Tae Kim
HKHyon Joo Kwag
Hyon Joo Kwag
KSKi-Chul Sung
Ki-Chul Sung
Background: Reduced lung function is associated with incident insulin resistance and diabetes. The aim of this study was to assess the relationship between lung function and incident type 2 diabetes in Korean men. Methods: This study included 9,220 men (mean age: 41.4 years) without type 2 diabetes at baseline who were followed for five years. Subjects were divided into four groups according to baseline forced vital capacity (FVC) (% predicted) and forced expiratory volume in one second (FEV1) (% predicted) quartiles. The incidence of type 2 diabetes at follow-up was compared according to FVC and FEV1 quartiles. Results: The overall incidence of type 2 diabetes was 2.2%. Reduced lung function was significantly associated with the incidence of type 2 diabetes after adjusting for age, BMI, education, smoking, exercise, alcohol, and HOMA-IR. Both FVC and FEV1 were negatively associated with type 2 diabetes (P < 0.05). In non-obese subjects with BMI < 25, the lowest quartile of FVC and FEV1 had a significantly higher odds ratio for type 2 diabetes compared with the highest quartile after adjusting for age and BMI (2.15 [95% CI 1.02-4.57] and 2.19 [95% CI 1.09-4.42]). Conclusions: Reduced lung function is independently associated with the incidence of type 2 diabetes in Korean men.

1 January 2017 in Korean Journal of Anesthesiology
Verified
Journal Article
Open access
PDF file
CKChang Hee Kwon
Chang Hee Kwon
SKSeong-Hyop Kim
Seong-Hyop Kim
Kwon CH, et al. Korean J Anesthesiol. 2017 Apr;70(2):120-126. https://doi.org/10.4097/kjae.2017.70.2.120

15 February 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ICIn-Jeong Cho
In-Jeong Cho
JSJeong-Hun Shin
Jeong-Hun Shin
MJMi-Hyang Jung
Mi-Hyang Jung
CKChaeyeong Kang
Chaeyeong Kang
JHJinseub Hwang
Jinseub Hwang
KSKi-Chul Sung
Ki-Chul Sung
We sought to assess the association between common antihypertensive drugs and the risk of incident cancer in treated hypertensive patients. Using the Korean National Health Insurance Service database, the risk of cancer incidence was analyzed in patients with hypertension who were initially free of cancer and used the following antihypertensive drug classes: Angiotensin-converting enzyme inhibitors (ACEIs); angiotensin receptor blockers (ARBs); beta blockers (BBs); calcium channel blockers (CCBs); and diuretics. During a median follow-up of 8.6 years, there were 4513 (6.4%) overall cancer incidences from an initial 70,549 individuals taking antihypertensive drugs. ARB use was associated with a decreased risk for overall cancer in a crude model (hazard ratio (HR): 0.744, 95% confidence interval (CI): 0.696–0.794) and a fully adjusted model (HR: 0.833, 95% CI: 0.775–0.896) compared with individuals not taking ARBs. Other antihypertensive drugs, including ACEIs, CCBs, BBs, and diuretics, did not show significant associations with incident cancer overall. The long-term use of ARBs was significantly associated with a reduced risk of incident cancer over time. The users of common antihypertensive medications were not associated with an increased risk of cancer overall compared to users of other classes of antihypertensive drugs. ARB use was independently associated with a decreased risk of cancer overall compared to other antihypertensive drugs.

6 April 2021 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
JSJeong-Hun Shin
Jeong-Hun Shin
MJMi-Hyang Jung
Mi-Hyang Jung
CKChang Hee Kwon
Chang Hee Kwon
CLChan Joo Lee
Chan Joo Lee
DKDae-Hee Kim
Dae-Hee Kim
KSKi-Chul Sung
Ki-Chul Sung
Background: Socioeconomic status is associated with differences in risk factors of cardiovascular disease and increased risks of cardiovascular disease and mortality. However, it is unclear whether an association exists between cardiovascular disease and income, a common measure of socioeconomic status, among patients with hypertension. Methods and Results: This population‐based longitudinal study comprised 479 359 patients aged ≥19 years diagnosed with essential hypertension. Participants were categorized by income and blood pressure levels. Primary end point was all‐cause and cardiovascular mortality and secondary end points were cardiovascular events, a composite of cardiovascular death, myocardial infarction, and stroke. Low income was significantly associated with high all‐cause (hazard ratio [HR], 1.26; 95% CI, 1.23–1.29, lowest versus highest income) and cardiovascular mortality (HR, 1.31; 95% CI, 1.25–1.38) as well as cardiovascular events (HR, 1.07; 95% CI, 1.05–1.10) in patients with hypertension after adjusting for age, sex, systolic blood pressure, body mass index, smoking status, alcohol consumption, physical activity, fasting glucose, total cholesterol, and the use of aspirin or statins. In each blood pressure category, low‐income levels were associated with high all‐cause and cardiovascular mortality and cardiovascular events. The excess risks of all‐cause and cardiovascular mortality and cardiovascular events associated with uncontrolled blood pressure were more prominent in the lowest income group. Conclusions: Low income and uncontrolled blood pressure are associated with increased all‐cause and cardiovascular mortality and cardiovascular events in patients with hypertension. These findings suggest that income is an important aspect of social determinants of health that has an impact on cardiovascular outcomes in the care of hypertension.

1 March 2020 in The American Journal of Cardiology
Verified
Journal Article
Closed access
KSKi-Chul Sung
Ki-Chul Sung
CKChang Hee Kwon
Chang Hee Kwon
MLMi Yeon Lee
Mi Yeon Lee
MKMin-Jung Kwon
Min-Jung Kwon
JLJu Hee Lee
Ju Hee Lee
JSJeong-Hun Shin
Jeong-Hun Shin

Verified
Journal Article
Open access
PDF file
CKChang Hee Kwon
Chang Hee Kwon
Hyeongsu KimHyeongsu Kim
Hyeongsu Kim
Sung Hea KimSung Hea Kim
Sung Hea Kim
BKBum Sung Kim
Bum Sung Kim
HKHyun-Joong Kim
Hyun-Joong Kim
KRKyu-Hyung Ryu
Kyu-Hyung Ryu
Aims: To evaluate the impact of metabolic syndrome (MetS) status on the incidence of atrial fibrillation (AF) in Koreans. Methods and results: Data obtained from the Korean National Health Insurance Service from 2009 to 2016 were analyzed. In total, 7,830,602 men and women (between 30 and 69 years of age) without baseline AF who underwent a national health examination between January 2009 and December 2009 were enrolled. Patients were evaluated to determine the impact of MetS status on their risk of developing AF until December 2016. Using the National Cholesterol Education Program Adult Treatment Panel III criteria, patients were placed into one of three groups depending on MetS component numbers: 0 (normal), 1–2 (Pre-MetS) or 3–5 (MetS). During a mean follow-up of 7.3 years, 20,708 subjects (0.26%) were diagnosed with AF. After multivariable adjustment, the risk of AF was significantly and positively correlated with MetS status (hazard ratios (HR) 1.391, 95% confidence interval (CI) 1.322–1.464 in Pre-MetS and HR 1.722, 95% CI 1.621–1.829 in MetS). When subgroup analyses were conducted according to MetS components, abdominal obesity (HR 1.316, p < 0.001), elevated blood pressure (HR 1.451, p < 0.001), and elevated fasting glucose (HR 1.163, p < 0.001) were associated with an increased risk of AF. Conclusion: MetS and pre-MetS are significantly associated with an increased risk of AF in Korean adults. Of the MetS components, abdominal obesity, elevated blood pressure, and elevated fasting glucose are potent risk factors for the risk of AF in this population.